Publications 2022

Hess G, Hüttmann A, Witzens-Harig M, Dreyling MH, Keller U, Marks R, Ernst T, Pott C, Viardot A, Frontzek F, Trautmann M, Ruckes C, Deuster O, Rosenwald A, Theobald M, Lenz G. A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. Br J Haematol. 2022 Aug;198(3):482-491. doi: 10.1111/bjh.18161. Epub 2022 Apr 1. PMID: 35362552

Koschmieder S, Isfort S, Wolf D, Heidel FH, Hochhaus A, Schafhausen P, Griesshammer M, Wolleschak D, Platzbecker U, Döhner K, Jost PJ, Parmentier S, Schaich M, von Bubnoff N, Stegelmann F, Maurer A, Crysandt M, Gezer D, Kortmann M, Franklin J, Frank J, Hellmich M, Brümmendorf TH; German Study Group for Myeloproliferative Neoplasms (GSG-MPN). Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group. Ann Hematol. 2022 Dec 23. doi: 10.1007/s00277-022-05080-7. Epub ahead of print. PMID: 36564535

Wittwer A, Sponholz K, Frietsch JJ, Linke P, Kropp P, Hochhaus A, Hilgendorf I. Psychosocial distress in young adults surviving hematological malignancies: a pilot study. J Cancer Res Clin Oncol. 2023 Aug;149(9):5655-5663. doi: 10.1007/s00432-022-04527-8. Epub 2022 Dec 17. PMID: 36527483; PMCID: PMC10356626

Wu JMF, Bekfani T, Hinze A, Westphal JG, Steinacker B, Zeller M, Hartmann C, Möbius-Winkler S, Hochhaus A, Schulze PC, Ernst T. Clonal haematopoiesis of indeterminate potential-related mutations and outcome in dilated and ischaemic cardiomyopathy. ESC Heart Fail. 2022 Dec;9(6):3954-3960. doi: 10.1002/ehf2.14115. Epub 2022 Aug 18. PMID: 35979940

Cortes JE, Hochhaus A, Takahashi N, Larson RA, Issa GC, Bombaci F, Ramscar N, Ifrah S, Hughes TP. Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future Oncol. 2022 Dec 16. doi: 10.2217/fon-2022-0923. Epub ahead of print. PMID: 36524980

Kastrati K, Mathies V, Kipp AP, Huebner J. Patient-reported experiences with side effects of kidney cancer therapies and corresponding information flow. J Patient Rep Outcomes. 2022 Dec 16;6(1):126. doi: 10.1186/s41687-022-00533-z. PMID: 36525162; PMCID: PMC9758261

Schrenk KG, Weschenfelder W, Spiegel C, Agaimy A, Stöhr R, Hartmann A, Gaßler N, Drescher R, Freesmeyer M, Malouhi A, Bürckenmeyer F, Aschenbach R, Teichgräber U, Kögler C, Vogt M, Hofmann GO, Hochhaus A. Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma. J Cancer Res Clin Oncol. 2022 Dec 5. doi: 10.1007/s00432-022-04496-y. Epub ahead of print. PMID: 36469155

Stein A, Paschold L, Tintelnot J, Goekkurt E, Henkes SS, Simnica D, Schultheiss C, Willscher E, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich T, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Sinn M, Lindig U, Hiegl W, Hinke A, Hegewisch-Becker S, Binder M. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial. JAMA Oncol. 2022 Aug 1;8(8):1150-1158. doi: 10.1001/jamaoncol.2022.2228. PMID: 35737383; PMCID: PMC9227706

Vogel A, Sterneck M, Vondran F, Waidmann O, Klein I, Lindig U, Nadalin S, Settmacher U, Tacke F, Schlitt HJ, Wege H. Der Einsatz der immunonkologischen Therapie beim hepatozellulären Karzinom im Kontext der Lebertransplantation Eine interdisziplinäre Risiko-Nutzen-Abwägung [The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment]. Z Gastroenterol. 2022 Feb;60(2):184-191. German. doi: 10.1055/a-1649-8643. Epub 2021 Oct 20. PMID: 34670296

Hübner J, Keinki C, Münstedt K: Alternativmedizin in der Uroonkologie. Urologie (2022). https://doi.org/10.1007/s00120-022-01990-6

Drexler U, Dörfler J, von Grundherr J, Erickson N, Hübner J: Fasting during cancer treatment: a systematic review. Qual Life Res (2022). https://doi.org/10.1007/s11136-022-03300-1

Dreger P, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner E, Wulf G, Marks R, Penack O, Schnetzke U, Koenecke C, von Bonin M, Stelljes M, Glass B, Baldus CD, Vucinic V, Mougiakakos D, Topp M, Schroers R, Wolff D, Thomas S, Kröger N, Bethge WA; German Lymphoma Alliance (GLA); German Stem Cell Transplantation Registry (DRST). Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience. Bone Marrow Transplant. 2022 Nov 22. doi: 10.1038/s41409-022-01867-4. Epub ahead of print. PMID: 36418916

Brüggemann M, Pott C, Stübig T, Kneba M, Hochhaus A (2022). Marker für minimale Resterkrankung: Minimal Residual Disease. In: Schmoll, HJ. (eds) Kompendium Internistische Onkologie . Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46764-0_153-1

Brioli A, Wyrwa A, Rüddel U, Yomade O, Lindig U, Franz W, Wacker HH, Gaßler N, Schweyer S, Chung HY, Axer H, Witte OW, Hochhaus A, Schrenk KG. Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma. Ann Hematol. 2022 Nov 19. doi: 10.1007/s00277-022-05032-1. Epub ahead of print. PMID: 36401620

Henß H, Hübner J: Kompendium Seltene Tumoren. 2022; Zuckschwerdt (Verlag), 978-3-86371-353-9 (ISBN)

Festerling L, Buentzel J, Fischer von Weikersthal L, Junghans C, Zomorodbakhsch B, Stoll C, Prott FJ, Fuxius S, Micke O, Richter A, Sallmann D, Huebner J, Hoppe C. Resilience in cancer patients and how it correlates with demographics, psychological factors, and lifestyle. J Cancer Res Clin Oncol. 2022 Nov 18. doi: 10.1007/s00432-022-04480-6. Epub ahead of print. PMID: 36396875

Hehlmann R, Lauseker M, Voskanyan A, Fabarius A, Haferlach C, Hochhaus A, Saußele S: Impact of emerging ACA on survival in chronic myeloid leukemia (CML). Leukemia 36, 2544–2547 (2022). https://doi.org/10.1038/s41375-022-01681-3

Hübner J. Integrative oncology-the best from one world. J Cancer Res Clin Oncol. 2022 Dec;148(12):3225-3226. doi: 10.1007/s00432-022-04168-x. Epub 2022 Jul 1. PMID: 35776195; PMCID: PMC9587103

Hübner J, Dörfler J, Liebl C, Käsmann L: Answer to Commentary on “Systematic review about complementary medical hyperthermia in oncology” by Liebl et al.. Clin Exp Med (2022). https://doi.org/10.1007/s10238-022-00901-5

Maschmeyer G, Loibl S, Fehm T, Hilgendorf I, Dittrich R: Management onkologischer Erkrankungen in der Schwangerschaft. Forum (2022). https://doi.org/10.1007/s12312-022-01134-z

Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schäfer-Eckart K, Steffen B, Sauer T, Krause SW, Schliemann C, Mikesch JH, Kaufmann M, Hänel M, Jost E, Brümmendorf TH, Fransecky L, Kraus S, Einsele H, Niemann D, Neubauer A, Kullmer J, Seggewiss-Bernhard R, Görner M, Held G, Kaiser U, Scholl S, Hochhaus A, Reinhardt HC, Platzbecker U, Baldus CD, Müller-Tidow C, Bornhäuser M, Serve H, Röllig C; Study Alliance Leukemia (SAL). Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry. J Cancer Res Clin Oncol. 2022 Sep 28. doi: 10.1007/s00432-022-04356-9. Epub ahead of print. PMID: 36167894

Gavriilaki E, Labopin M, Sakellari I, Salmenniemi U, Yakoub-Agha I, Potter V, Berceanu A, Rambaldi A, Hilgendorf I, Kröger N, Mielke S, Zuckerman T, Sanz J, Busca A, Ozdogu H, Anagnostopoulos A, Savani B, Giebel S, Bazarbachi A, Spyridonidis A, Nagler A, Mohty M. Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP). Bone Marrow Transplant. 2022 Sep 22. doi: 10.1038/s41409-022-01830-3. Epub ahead of print. PMID: 36138068

Baron von Osthoff M, Watzlaw-Schmidt U, Lehmann T, Hübner J. Patientengruppenspezifische Datenhoheitsbedürfnisse und Akzeptanz der elektronischen Patientenakte [Patient group-specific data sovereignty needs and acceptance of electronic health records]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Sep 23. German. doi: 10.1007/s00103-022-03589-w. Epub ahead of print. PMID: 36149472

Münstermann J, Hübner J, Büntzel J. Can Cancer Education Programs Improve Health Literacy Among Deaf and Hard of Hearing Patients: a Systematic Review. J Cancer Educ. 2022 Sep 19. doi: 10.1007/s13187-022-02222-3. Epub ahead of print. PMID: 36117200

Hübner J, Welter S, Ciarlo G, Käsmann L, Ahmadi E, Keinki C. Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients. Med Oncol. 2022 Sep 7;39(12):192. doi: 10.1007/s12032-022-01796-8. PMID: 36071252

Kunadt D, Stasik S, Metzeler KH, Röllig C, Schliemann C, Greif PA, Spiekermann K, Rothenberg-Thurley M, Krug U, Braess J, Krämer A, Hochhaus A, Scholl S, Hilgendorf I, Brümmendorf TH, Jost E, Steffen B, Bug G, Einsele H, Görlich D, Sauerland C, Schäfer-Eckart K, Krause SW, Hänel M, Hanoun M, Kaufmann M, Wörmann B, Kramer M, Sockel K, Egger-Heidrich K, Herold T, Ehninger G, Burchert A, Platzbecker U, Berdel WE, Müller-Tidow C, Hiddemann W, Serve H, Stelljes M, Baldus CD, Neubauer A, Schetelig J, Thiede C, Bornhäuser M, Middeke JM, Stölzel F; A. M. L. Cooperative Group (AMLCG), Study Alliance Leukemia (SAL). Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. J Hematol Oncol. 2022 Sep 5;15(1):126. doi: 10.1186/s13045-022-01339-8. PMID: 36064577

Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, Apperley J, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton J, Nicolini FE, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Shah NP, Talpaz M, Srivastava S, Ren X, Mauro M: Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. Am J Hematol. 2022; 97( 11): 1419- 1426. doi:10.1002/ajh.26686

Ott KU, Keinki C, Kaesmann L, Hübner J: Education of complementary and alternative medicine in adult education centers in Germany: a web-based survey. Wien Med Wochenschr (2022). https://doi.org/10.1007/s10354-022-00951-0

Wu JMF, Bekfani T, Hinze A, Westphal JG, Steinacker B, Zeller M, Hartmann C, Möbius-Winkler S, Hochhaus A, Schulze PC, Ernst T. Clonal haematopoiesis of indeterminate potential-related mutations and outcome in dilated and ischaemic cardiomyopathy. ESC Heart Fail. 2022 Aug 18. doi: 10.1002/ehf2.14115. Epub ahead of print. PMID: 35979940

Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-Toal M, Teschner D, Jordan K, Müller-Tidow C, Egerer G, Giesen N. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding. PLoS One. 2022 Jul 29;17(7):e0271756. doi: 10.1371/journal.pone.0271756. PMID: 35905071; PMCID: PMC9337657

Soverini S, De Santis S, Martelli M, Monaldi C, Castagnetti F, Gugliotta G, Papayannidis C, Mancini M, Bruno S, Venturi C, Machova Polakova K, Ernst T, Maar D, Corner A, Cavo M. Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia. Leukemia. 2022 Jul 30. doi: 10.1038/s41375-022-01660-8. Epub ahead of print. PMID: 35908105

Einsele H, Steutel H, Eichhorst B, Göbeler ME, Hochhaus A, Nickel L, von Messling V, Deggerich A, Nettekoven G. [Klinische Studien in der Hämatologie und Onkologie]. Oncol Res Treat. 2022 Jul 22;45 Suppl 1:6-32. German. doi: 10.1159/000525371. Epub ahead of print. PMID: 35871514

Heilfort L, Kutschan S, Dörfler J, Freuding M, Büntzel J, Münstedt K, Hübner J (2022): A Systematic Review of the Benefit of B-Vitamins as a Complementary Treatment in Cancer Patients, Nutrition and Cancer, DOI: 10.1080/01635581.2022.2098348

Stege, H.; Schneider, S.; Forschner, A.; Eigentler, T.; Nashan, D.; Huening, S.; Meiss, F.; Lehr, S.; Kaatz, M.; Kuchen, R.; Kaehler, K.C.; Haist, M.; Huebner, J.; Loquai, C. eHealth Literacy in German Skin Cancer Patients. Int. J. Environ. Res. Public Health 2022, 19, 8365. https://doi.org/10.3390/ijerph19148365

Liebl CM, Kutschan S, Dörfler J, Käsmann L, Hübner J. Systematic review about complementary medical hyperthermia in oncology. Clin Exp Med. 2022 Jun 29:1–47. doi: 10.1007/s10238-022-00846-9. Epub ahead of print. PMID: 35767077; PMCID: PMC9244386

CiteStein A, Paschold L, Tintelnot J, Goekkurt E, Henkes SS, Simnica D, Schultheiss C, Willscher E, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich T, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Sinn M, Lindig U, Hiegl W, Hinke A, Hegewisch-Becker S, Binder M. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial. JAMA Oncol. 2022 Jun 23. doi: 10.1001/jamaoncol.2022.2228. Epub ahead of print. PMID: 35737383

Wagenknecht A, Dörfler J, Freuding M, Josfeld L, Huebner J. Homeopathy effects in patients during oncological treatment: a systematic review. J Cancer Res Clin Oncol. 2022 Jun 22. doi: 10.1007/s00432-022-04054-6. Epub ahead of print. PMID: 35731274

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22. PMID: 35732829; PMCID: PMC9214472

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22. PMID: 35732831; PMCID: PMC9252913

Brioli A, Nägler TM, Yomade O, Rüthrich MM, Scholl S, Frietsch JJ, Hilgendorf I, Ernst T, Sayer HG, Hochhaus A, Mügge LO, von Lilienfeld-Toal M. Sex-disaggregated analysis of biology, treatment tolerability and outcome of Multiple Myeloma in a German cohort. Oncol Res Treat. 2022 Jun 15. doi: 10.1159/000525493. Epub ahead of print. PMID: 35705004

Salmon M, White HE, Zizkova H, Gottschalk A, Motlova E, Cerveira N, Colomer D, Coriu D, Franke GN, Gottardi E, Izzo B, Jurcek T, Lion T, Schäfer V, Venturi C, Vigneri P, Zawada M, Zuna J, Hovorkova L, Koblihova J, Klamova H, Markova MS, Srbova D, Benesova A, Polivkova V, Zackova D, Mayer J, Roeder I, Glauche I, Ernst T, Hochhaus A, Polakova KM, Cross NCP. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. Leukemia. 2022 Jul;36(7):1879-1886. doi: 10.1038/s41375-022-01612-2. Epub 2022 Jun 8. PMID: 35676453; PMCID: PMC9252903

Zomorodbakhsch, B., Hübner, J. Cannabis bei Krebs – für welchen Einsatz haben wir Evidenz?. Onkologie (2022). https://doi.org/10.1007/s00761-022-01197-6

Ernst P, Schnöder TM, Huber N, Perner F, Jayavelu AK, Eifert T, Hsu CJ, Tubío-Santamaría N, Crodel CC, Ungelenk M, Hübner CA, Clement JH, Hochhaus A, Heidel FH. Histone demethylase KDM4C is a functional dependency in JAK2-mutated neoplasms. Leukemia. 2022 Jul;36(7):1843-1849. doi: 10.1038/s41375-022-01611-3. Epub 2022 Jun 2. PMID: 35654819; PMCID: PMC9252905

Brümmendorf TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, Clark RE, le Coutre P, Garcia-Gutierrez V, Chuah C, Kota V, Lipton JH, Rousselot P, Mauro MJ, Hochhaus A, Hurtado Monroy R, Leip E, Purcell S, Yver A, Viqueira A, Deininger MW; BFORE study investigators. Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. Leukemia. 2022 Jul;36(7):1825-1833. doi: 10.1038/s41375-022-01589-y. Epub 2022 May 28. PMID: 35643868; PMCID: PMC9252917

Scholl S, Eich H, Höffken K: Akute Leukämien. Onkologie 28, 453–454 (2022). https://doi.org/10.1007/s00761-022-01168-x

Scholl S: Primär- und Rezidivtherapie akuter Leukämien. Onkologie 28, 455–458 (2022). https://doi.org/10.1007/s00761-022-01167-y

Fleischmann M, Schnetzke U, Hochhaus, A, Scholl S: Ziele und Optionen der palliativen Therapie der akuten myeloischen Leukämie. Onkologie 28, 483–491 (2022). https://doi.org/10.1007/s00761-022-01151-6

White HE, Salmon M, Albano F, Andersen CSA, Balabanov S, Balatzenko G, Barbany G, Cayuela JM, Cerveira N, Cochaux P, Colomer D, Coriu D, Diamond J, Dietz C, Dulucq S, Engvall M, Franke GN, Gineikiene-Valentine E, Gniot M, Gómez-Casares MT, Gottardi E, Hayden C, Hayette S, Hedblom A, Ilea A, Izzo B, Jiménez-Velasco A, Jurcek T, Kairisto V, Langabeer SE, Lion T, Meggyesi N, Mešanović S, Mihok L, Mitterbauer-Hohendanner G, Moeckel S, Naumann N, Nibourel O, Oppliger Leibundgut E, Panayiotidis P, Podgornik H, Pott C, Rapado I, Rose SJ, Schäfer V, Touloumenidou T, Veigaard C, Venniker-Punt B, Venturi C, Vigneri P, Vorkinn I, Wilkinson E, Zadro R, Zawada M, Zizkova H, Müller MC, Saussele S, Ernst T, Machova Polakova K, Hochhaus A, Cross NCP. Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia. 2022 Jul;36(7):1834-1842. doi: 10.1038/s41375-022-01607-z. Epub 2022 May 25. PMID: 35614319; PMCID: PMC9252906

Fendler A., de Vries EGE, GeurtsvanKessel, CH, Haanen JB, Wörmann B, Turajlic S, Lilienfeld-Toal M: COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety. Nat Rev Clin Oncol 19, 385–401 (2022). https://doi.org/10.1038/s41571-022-00610-8

Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J, Glaser A, Thiede C, Hochhaus A, Scholl S. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. J Cancer Res Clin Oncol. 2022 May 18. doi: 10.1007/s00432-022-03995-2. Epub ahead of print. PMID: 35583829

Eckardt JN, Stölzel F, Kunadt D, Röllig C, Stasik S, Wagenführ L, Jöhrens K, Kuithan F, Krämer A, Scholl S, Hochhaus A, Crysandt M, Brümmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause SW, Herbst R, Hänel M, Hanoun M, Kaiser U, Kaufmann M, Rácil Z, Mayer J, Kroschinsky F, Berdel WE, Ehninger G, Serve H, Müller-Tidow C, Platzbecker U, Baldus CD, Schetelig J, Bornhäuser M, Thiede C, Middeke JM. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations. J Hematol Oncol. 2022 May 13;15(1):60. doi: 10.1186/s13045-022-01267-7. PMID: 35562747

Frietsch JJ, Miethke J, Linke P, Crodel CC, Schnetzke U, Scholl S, Hochhaus A, Hilgendorf I. Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma. Bone Marrow Transplant. 2022 Jul;57(7):1164-1170. doi: 10.1038/s41409-022-01701-x. Epub 2022 May 10. PMID: 35538141; PMCID: PMC9262709

Hochhaus, A., Ernst, T. Weißes Blut. Onkologe (2022). https://doi.org/10.1007/s00761-022-01135-6

Fleischmann M, Schnetzke U, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Huebner J: Ziele und Optionen der palliativen Therapie der akuten myeloischen Leukämie. Onkologe (2022). https://doi.org/10.1007/s00761-022-01151-6

Wolf CPJG, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Huebner J. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. J Cancer Res Clin Oncol. 2022 May;148(5):1123-1135. doi: 10.1007/s00432-021-03675-7. Epub 2021 Jul 6. PMID: 34228225

Hoang TNM, Cseresnyés Z, Hartung S, Blickensdorf M, Saffer C, Rennert K, Mosig AS, von Lilienfeld-Toal M, Figge MT. Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection. Biomaterials. 2022 Apr;283:121420. doi: 10.1016/j.biomaterials.2022.121420. Epub 2022 Feb 24. PMID: 35245733

Goldmann M, Schmidt F, Cseresnyés Z, Orasch T, Jahreis S, Hartung S, Figge MT, von Lilienfeld-Toal M, Heinekamp T, Brakhage AA: The lipid raft-associated protein stomatin is required for accumulation of dectin-1 in the phagosomal membrane and for full activity of macrophages against Aspergillus fumigatus. bioRxiv preprint DOI: https://doi.org/10.1101/2022.02.25.481948, Posted: February 25, 2022, Version 1

DiNardo CD, Hochhaus A, Frattini MG, Yee K, Zander T, Krämer A, Chen X, Ji Y, Parikh NS, Choi J, Wei AH. A phase 1 study of IDH305 in patients with IDH1R132-mutant acute myeloid leukemia or myelodysplastic syndrome. J Cancer Res Clin Oncol. 2022 Mar 30. doi: 10.1007/s00432-022-03983-6. Epub ahead of print. PMID: 35353219

Bethge WA, Martus P, Schmitt M, Holtick U, Subklewe M, von Tresckow B, Ayuk F, Wagner-Drouet EM, Wulf GG, Marks R, Penack O, Schnetzke U, Koenecke C, von Bonin M, Stelljes M, Glass B, Baldus CD, Vucinic V, Mougiakakos D, Topp MS, Fante MA, Schroers R, Bayir LM, Borchmann P, Buecklein V, Hanoun C, Thomas S, Beelen DW, Lengerke C, Kroeger N, Dreger P. GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany. Blood. 2022 Mar 22:blood.2021015209. doi: 10.1182/blood.2021015209. Epub ahead of print. PMID: 35316325

Saglio G, Rosti G, Hehlmann R, Hochhaus A, Gale RP. Prof. Michele Baccarani, August 16, 1942 to December 20, 2021: a gifted life in haematology. Bone Marrow Transplant. 2022 Mar 16. doi: 10.1038/s41409-022-01636-3. Epub ahead of print. PMID: 35297405

O'Hagan Henderson S, Glaser A, Frietsch JJ, Hochhaus A, Hilgendorf I. The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm. Ann Hematol. 2022 Apr;101(4):919-920. doi: 10.1007/s00277-021-04655-0. Epub 2021 Sep 1. PMID: 34471943; PMCID: PMC8913527

Schaffrath J, Brummer C, Wolff D, Holtick U, Kröger N, Bornhäuser M, Kraus S, Hilgendorf I, Blau IW, Penack O, Wittke C, Steiner N, Nachbaur D, Thurner L, Hindah H, Zeiser R, Maier CP, Bethge W, Müller LP. High mortality of COVID-19 early after allogeneic stem cell transplantation - a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group. Transplant Cell Ther. 2022 Mar 13:S2666-6367(22)00158-0. doi: 10.1016/j.jtct.2022.03.010. Epub ahead of print. PMID: 35296445; PMCID: PMC8918088

Fendler A, de Vries EGE, GeurtsvanKessel CH, GeurtsvanKessel CH, Haanen JB, Wörmann B, Turajlic S, von Lilienfeld-Toal M: COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety. Nat Rev Clin Oncol (2022). https://doi.org/10.1038/s41571-022-00610-8

Keinki C, Rudolph I, Wozniak T, Pietsch R, Margolina M, Garcia I, Mayr-Welschlau K, Schmidt T, Hübner J. A virtual dance sport class for cancer patients: the trainer perspective. J Cancer Res Clin Oncol. 2022 Mar 7. doi: 10.1007/s00432-022-03913-6. Epub ahead of print. PMID: 35253086

Saglio G, Rosti G, Hehlmann R, Hochhaus A, Gale RP: Prof. Michele Baccarani. August 16, 1942 to December 20, 2021: a gifted life in haematology. Leukemia (2022). https://doi.org/10.1038/s41375-022-01525-0

Topp MS, Eradat H, Florschütz A, Hochhaus A, Wrobel T, Walewski J, Knopinska-Posluszny W, Kanate AS, Lech-Maranda E, Brunnberg U, Chitra S, Nielsen TG, Sellam G, Shivhare M, Lossos IS. Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Feb 18. doi: 10.1007/s00432-021-03847-5. Epub ahead of print. PMID: 35182224

Fleischmann M, Scholl S, Frietsch JJ, Hilgendorf I, Schrenk K, Hammersen J, Prims F, Thiede C, Hochhaus A, Schnetzke U. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia. J Cancer Res Clin Oncol. 2022 Nov;148(11):3191-3202. doi: 10.1007/s00432-022-03930-5. Epub 2022 Jan 31. PMID: 35099591; PMCID: PMC9508061

Hochhaus A, Krause M, Schmidberger H. Molekulare Onkologie. Onkologe 28, 92–94 (2022). https://doi.org/10.1007/s00761-022-01095-x

Hübner J, Ciarlo G, Dubois C, Münstedt K, Micke O, Büntzel J, Klein M, Josfeld L, Keinki C. Komplementär- und alternativmedizinische Angebote von Lehrpraxen für Allgemeinmedizin [Complementary and Alternative Medicine Offers of Teaching Practices for General Medicine]. Gesundheitswesen. 2022 Jan 11. German. doi: 10.1055/a-1690-6631. Epub ahead of print. PMID: 35016252

Januzzi JL, Garasic JM, Kasner SE, McDonald V, Petrie MC, Seltzer J, Mauro M, Croce K, Berman E, Deininger M, Hochhaus A, Pinilla-Ibarz J, Nicolini F, Kim DW, DeAngelo DJ, Kantarjian H, Xu J, Hall T, Srivastava S, Naranjo D, Cortes J. Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 Jan 6;15(1):1. doi: 10.1186/s13045-021-01221-z. PMID: 34991679

Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, Krämer A, Scholl S, Hochhaus A, Brümmendorf TH, Naumann R, Petzold A, Mulet-Lazaro R, Valk PJM, Steffen B, Einsele H, Schaich M, Burchert A, Neubauer A, Schäfer-Eckart K, Schliemann C, Krause SW, Hänel M, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Herold S, Stölzel F, Sockel K, von Bonin M, Müller-Tidow C, Platzbecker U, Berdel WE, Serve H, Ehninger G, Bornhäuser M, Schetelig J, Thiede C; Study Alliance Leukemia (SAL). CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome. Blood. 2022 Jan 6;139(1):87-103. doi: 10.1182/blood.2020009680. PMID: 34320176